Extrachromosomal circular DNA (eccDNA) undergoes self-aggregation and phase separation with HOXD13 to confer chemotherapy resistance

Abstract Extrachromosomal circular DNA (eccDNA) has emerged as a critical regulator driving malignant progression and therapeutic resistance in multiple cancers, yet its molecular mechanism remains poorly defined. Here, we demonstrate that eccDNA could undergo self-aggregation in vivo and in vitro , and interacted with HOXD13 protein. EccDNA promotes Esophageal Squamous Cell Carcinoma (ESCC) cell proliferation, migration, and cisplatin resistance by modulating HOXD13 condensate dynamics. Ectopic delivery of eccDNA restored cisplatin resistance in HOXD13-knockout ESCC cells, while depletion of HOXD13 abolished this phenotype. Functional assays including CCK-8, EDU incorporation and Transwell assays revealed that silencing HOXD13 markedly suppressed ESCC cell proliferation, DNA synthesis, and migratory capacity in vitro . Mechanistically, eccDNA or chemical cross-linking agents induced the formation of HOXD13 condensates, which distributed either the nucleus or cytoplasm. Screening of nucleocytoplasmic transport factors identified KPNB1 as the key importin mediating HOXD13 nuclear shuttling. Transcriptomic and CUT & Tag analysis revealed that eccDNA increased the immune response pathway and cancer signaling. In addition, we showed that eccDNA promoted the interaction of HOXD13 and NFκB. In xenograft mouse models, combined treatment with DNase I-mediated eccDNA clearance and cisplatin synergistically restrained tumor growth and elevated DNA damage compared with monotherapy. Collectively, our findings reveal a novel eccDNA-HOXD13 pathway that modulates ESCC malignancy and chemoresistance, highlighting eccDNA clearance as a promising strategy to improve the therapeutic efficacy of cisplatin in ESCC.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11591827/v1
Primary Topic
Circular RNAs in diseases
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Extrachromosomal circular DNA (eccDNA) undergoes self-aggregation and phase separation with HOXD13 to confer chemotherapy resistance

芮圆圆, Peng Tang, 张洪典, Fanbiao Meng et al.
3 links
Research Square
Circular RNAs in diseases
preprint

Extrachromosomal circular DNA (eccDNA) undergoes self-aggregation and phase separation with HOXD13 to confer chemotherapy resistance

芮圆圆, Peng Tang, 张洪典, Fanbiao Meng, Yongyin Gao, Baihui Li
preprint en

Abstract

Abstract Extrachromosomal circular DNA (eccDNA) has emerged as a critical regulator driving malignant progression and therapeutic resistance in multiple cancers, yet its molecular mechanism remains poorly defined. Here, we demonstrate that eccDNA could undergo self-aggregation in vivo and in vitro , and interacted with HOXD13 protein. EccDNA promotes Esophageal Squamous Cell Carcinoma (ESCC) cell proliferation, migration, and cisplatin resistance by modulating HOXD13 condensate dynamics. Ectopic delivery of eccDNA restored cisplatin resistance in HOXD13-knockout ESCC cells, while depletion of HOXD13 abolished this phenotype. Functional assays including CCK-8, EDU incorporation and Transwell assays revealed that silencing HOXD13 markedly suppressed ESCC cell proliferation, DNA synthesis, and migratory capacity in vitro . Mechanistically, eccDNA or chemical cross-linking agents induced the formation of HOXD13 condensates, which distributed either the nucleus or cytoplasm. Screening of nucleocytoplasmic transport factors identified KPNB1 as the key importin mediating HOXD13 nuclear shuttling. Transcriptomic and CUT & Tag analysis revealed that eccDNA increased the immune response pathway and cancer signaling. In addition, we showed that eccDNA promoted the interaction of HOXD13 and NFκB. In xenograft mouse models, combined treatment with DNase I-mediated eccDNA clearance and cisplatin synergistically restrained tumor growth and elevated DNA damage compared with monotherapy. Collectively, our findings reveal a novel eccDNA-HOXD13 pathway that modulates ESCC malignancy and chemoresistance, highlighting eccDNA clearance as a promising strategy to improve the therapeutic efficacy of cisplatin in ESCC.

Research Square
Tianjin Medical University Cancer Institute and Hospital (CN)
National Natural Science Foundation of China, Tianjin Municipal Education Commission
Good health and well-being
Circular RNAs in diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon